| Application | Comment | Organism |
|---|---|---|
| medicine | gasdermin D (GSDMD)-dependent pyroptosis mediated by caspase-11 might be a target in preventing the loss of renal tubular epithelial cells and inflammation in acute kidney injury (AKI) | Mus musculus |
| Protein Variants | Comment | Organism |
|---|---|---|
| additional information | generation of Casp-11-/- mice. Cisplatin-induced tubular dilation, loss of brush border, cast formation, and cell lysis in tubules are significantly ameliorated in Casp-11-/- mice. The level of urinary IL-18 is significantly suppressed in Casp-11-/- mice compared with wild-type mice after cisplatin treatment. Deletion of caspase-11 suppresses the infiltration of macrophages and neutrophils in cisplatin-induced acute kidney injury | Mus musculus |
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| gasdermin D + H2O | Mus musculus | - |
N-terminal domain of gasdermin D + C-terminal domain of gasdermin D | - |
? |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | P70343 | cf. caspase-4, EC 3.4.22.57 | - |
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| kidney | - |
Mus musculus | - |
| macrophage | - |
Mus musculus | - |
| neutrophil | - |
Mus musculus | - |
| renal tubular epithelial cell | - |
Mus musculus | - |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| gasdermin D + H2O | - |
Mus musculus | N-terminal domain of gasdermin D + C-terminal domain of gasdermin D | - |
? |
| Organism | Comment | Expression |
|---|---|---|
| Mus musculus | caspase-11 is upregulated of by either cisplatin or ischemia-reperfusion | up |
| General Information | Comment | Organism |
|---|---|---|
| malfunction | caspase-11 knockout mice exhibit attenuated deterioration of renal functional, reduced tubular damage, reduced macrophage and neutrophil infiltration, and decreased urinary IL-18 excretion after cisplatin treatment. Expression of caspase-11 is significantly increased after cisplatin or hypoxia-reoxygenation treatment. Knockout of GSDMD suppresses the excretion of IL-18 in urine after cisplatin treatment | Mus musculus |
| metabolism | caspase-11/GSDMD dependent tubule cell pyroptosis plays a significant role in initiating tubular cell damage, urinary IL-18 excretion and renal functional deterioration in acute kidney injury | Mus musculus |
| physiological function | caspase-11 is a cysteine protease that promotes cell pyroptosis. Cleavage of gasdermin D by caspase-11 promotes tubular epithelial cell pyroptosis and urinary IL-18 excretion in acute kidney injury. Inflammation and tubular cell death are the hallmarks of acute kidney injury. Upregulation of caspase-11 by either cisplatin or ischemia-reperfusion leads to cleavage of gasdermin D (GSDMD) into GSDMD-N, which translocates to the plasma membrane, thus triggering cell pyroptosis, and facilitates IL-18 release in primary cultured renal tubular cells. GSDMD is the specific substrate of caspasae-11 and the molecular biomarker of pyroptosis | Mus musculus |